Suppr超能文献

来自鼠尾草叶马先蒿中新克罗烷二萜的合成研究:萨尔维菌素A和B的半合成以及萨尔维诺灵A的其他化学转化

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.

作者信息

Harding Wayne W, Schmidt Matthew, Tidgewell Kevin, Kannan Pavitra, Holden Kenneth G, Gilmour Brian, Navarro Hernan, Rothman Richard B, Prisinzano Thomas E

机构信息

Division of Medicinal & Natural Products Chemistry, College of Pharmacy, The University of Iowa, Iowa City, Iowa 52242, USA.

出版信息

J Nat Prod. 2006 Jan;69(1):107-12. doi: 10.1021/np050398i.

Abstract

Salvinorin A (1) is a hallucinogenic neoclerodane diterpene isolated from the widely available psychoactive plant Salvia divinorum and is the first example of a non-nitrogenous opioid receptor ligand. At present, there is little information available as to why this compound is selective for kappa opioid receptors. One approach to better understanding the mode of binding of 1 at kappa receptors is to systematically alter the structure of 1 and examine the effects on opioid receptor affinity and activity. Currently, there is a paucity of methods described for the preparation of analogues derived from 1. Here, we report the investigation of several chemical transformations of 1 isolated from S. divinorum. In particular, this work provides a semisynthesis of salvinicins A (2) and B (3) and has identified 10a as the first neoclerodane diterpene with delta opioid antagonist activity.

摘要

萨尔维诺林A(1)是一种从广泛可得的精神活性植物鼠尾草中分离出的致幻新克罗烷二萜,是首个非含氮阿片受体配体的实例。目前,关于该化合物为何对κ阿片受体具有选择性的信息很少。更好地理解1在κ受体上的结合模式的一种方法是系统地改变1的结构,并研究其对阿片受体亲和力和活性的影响。目前,描述的从1制备类似物的方法很少。在此,我们报告了对从鼠尾草中分离出的1的几种化学转化的研究。特别是,这项工作提供了萨尔维菌素A(2)和B(3)的半合成,并确定10a为首个具有δ阿片拮抗剂活性的新克罗烷二萜。

相似文献

3
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.
Bioorg Med Chem Lett. 2007 Nov 15;17(22):6111-5. doi: 10.1016/j.bmcl.2007.09.050. Epub 2007 Sep 15.
4
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
Org Lett. 2005 Jul 7;7(14):3017-20. doi: 10.1021/ol0510522.
5
Synthesis of salvinorin A analogues as opioid receptor probes.
J Nat Prod. 2006 Jun;69(6):914-8. doi: 10.1021/np060094b.
6
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
J Med Chem. 2005 Jul 28;48(15):4765-71. doi: 10.1021/jm048963m.
7
Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A.
Org Lett. 2008 Apr 3;10(7):1365-8. doi: 10.1021/ol800101v. Epub 2008 Mar 1.
8
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
Org Biomol Chem. 2009 Sep 21;7(18):3748-56. doi: 10.1039/b905148a. Epub 2009 Jul 14.
9
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.
Bioorg Med Chem Lett. 2006 Jun 15;16(12):3170-4. doi: 10.1016/j.bmcl.2006.03.062. Epub 2006 Apr 18.

引用本文的文献

3
Total Syntheses of Marrubiin and Related Labdane Diterpene Lactones.
Molecules. 2020 Apr 1;25(7):1610. doi: 10.3390/molecules25071610.
4
A review of salvinorin analogs and their kappa-opioid receptor activity.
Bioorg Med Chem Lett. 2018 May 15;28(9):1436-1445. doi: 10.1016/j.bmcl.2018.03.029. Epub 2018 Mar 12.
5
Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.
J Nat Prod. 2017 Jul 28;80(7):2094-2100. doi: 10.1021/acs.jnatprod.7b00327. Epub 2017 Jul 18.
8
Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists.
J Nat Prod. 2014 Feb 28;77(2):311-9. doi: 10.1021/np4009046. Epub 2014 Jan 23.
9
Bio-efficacy of Dioscorea pentaphylla from Midmid-Western Ghats, India.
Toxicol Int. 2012 May;19(2):100-5. doi: 10.4103/0971-6580.97195.
10
Semisynthetic neoclerodanes as kappa opioid receptor probes.
Bioorg Med Chem. 2012 May 1;20(9):3100-10. doi: 10.1016/j.bmc.2012.02.040. Epub 2012 Mar 1.

本文引用的文献

2
Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
Bioorg Med Chem Lett. 2005 Oct 1;15(19):4169-73. doi: 10.1016/j.bmcl.2005.06.092.
3
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
J Med Chem. 2005 Jul 28;48(15):4765-71. doi: 10.1021/jm048963m.
4
Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.
Bioorg Med Chem Lett. 2005 Aug 15;15(16):3744-7. doi: 10.1016/j.bmcl.2005.05.048.
5
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
Org Lett. 2005 Jul 7;7(14):3017-20. doi: 10.1021/ol0510522.
6
Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2).
Bioorg Med Chem Lett. 2005 Jun 2;15(11):2761-5. doi: 10.1016/j.bmcl.2005.03.113.
7
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
J Med Chem. 2005 Jan 27;48(2):345-8. doi: 10.1021/jm049438q.
9
A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.
Bioorg Med Chem Lett. 2004 Oct 18;14(20):5099-102. doi: 10.1016/j.bmcl.2004.07.081.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验